| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1024681689 |
| P356 | DOI | 10.1186/1755-1536-5-S1-S22 |
| P932 | PMC publication ID | 3368792 |
| P698 | PubMed publication ID | 23259468 |
| P50 | author | Borna Mehrad | Q41554549 |
| P2093 | author name string | Robert M Strieter | |
| P2860 | cites work | The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. | Q52927020 |
| Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. | Q53135612 | ||
| Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis | Q61892487 | ||
| Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis | Q80977273 | ||
| Non-steroid agents for idiopathic pulmonary fibrosis | Q24235478 | ||
| Corticosteroids for idiopathic pulmonary fibrosis | Q24247945 | ||
| Immunomodulatory agents for idiopathic pulmonary fibrosis | Q24248714 | ||
| Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials | Q28237583 | ||
| Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial | Q28250518 | ||
| Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis | Q28260133 | ||
| An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management | Q28308246 | ||
| Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis | Q30435304 | ||
| Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease | Q30442380 | ||
| Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis | Q33942836 | ||
| Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification | Q34066372 | ||
| Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis | Q34223462 | ||
| CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury | Q34399563 | ||
| Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis | Q34554406 | ||
| A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis | Q34619709 | ||
| Bone marrow-derived progenitor cells in pulmonary fibrosis | Q35022598 | ||
| Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide | Q35163605 | ||
| The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial | Q35177613 | ||
| Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration. | Q35781428 | ||
| Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis | Q36849123 | ||
| The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? | Q36970923 | ||
| Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum | Q37110217 | ||
| EMT: when epithelial cells decide to become mesenchymal-like cells | Q37504554 | ||
| Chemokine (C-C motif) ligand 2 mediates direct and indirect fibrotic responses in human and murine cultured fibrocytes. | Q38917825 | ||
| Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis | Q40662352 | ||
| The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage | Q42039495 | ||
| Role of semaphorin 7a signaling in transforming growth factor β1-induced lung fibrosis and scleroderma-related interstitial lung disease | Q42061983 | ||
| The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. | Q42105688 | ||
| Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. | Q42154997 | ||
| The acute respiratory distress syndrome: fibrosis in the fast lane | Q43061295 | ||
| Idiopathic pulmonary fibrosis and pirfenidone | Q43113010 | ||
| Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results | Q43223134 | ||
| The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats. | Q44056582 | ||
| CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis | Q44650088 | ||
| C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases. | Q45147485 | ||
| BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis | Q46977247 | ||
| A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis | Q48033849 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | Suppl 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gastroenterology | Q120569 |
| pathogenesis | Q372016 | ||
| lung disease | Q3392853 | ||
| rheumatology | Q327657 | ||
| dermatology | Q171171 | ||
| P304 | page(s) | S22 | |
| P577 | publication date | 2012-06-06 | |
| P1433 | published in | Fibrogenesis and Tissue Repair | Q15816650 |
| P1476 | title | Fibrocytes and the pathogenesis of diffuse parenchymal lung disease | |
| P478 | volume | 5 |
| Q47653273 | Altered pattern of monocyte differentiation and monocyte-derived TGF-β1 in severe asthma. |
| Q33799560 | Bone marrow-derived stromal cells are invasive and hyperproliferative and alter transforming growth factor-α-induced pulmonary fibrosis |
| Q30362039 | Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome. |
| Q56480036 | Circulating fibrocytes as biomarkers of impaired lung function in adults with sickle cell disease |
| Q64274792 | Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets |
| Q47901631 | Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies |
| Q51068295 | Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis. |
| Q96022956 | Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice |
| Q37197964 | Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis |
Search more.